Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A16282 | 28471828 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease can be predicted by retinal vascular changes in patients with obesity without hypertension or diabetes. | 2017 | Details |
| A16283 | 28471823 | Eur J Gastroenterol Hepatol | The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review. | 2017 | Details |
| A16284 | 28471821 | Eur J Gastroenterol Hepatol | Diabetic status and grade of nonalcoholic fatty liver disease are associated with lower baroreceptor sensitivity in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16285 | 28471490 | Br J Pharmacol | Hydroxyeicosapentaenoic acids and epoxyeicosatetraenoic acids attenuate early occurrence of nonalcoholic fatty liver disease. | 2017 | Details |
| A16286 | 28471474 | J Cell Physiol | Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. | 2017 | Details |
| A16287 | 28471394 | Int J Mol Sci | Letter to the Editor: Bioinformatics Analysis in Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E. | 2017 | Details |
| A16288 | 28470881 | Aliment Pharmacol Ther | Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis. | 2017 | Details |
| A16289 | 28470683 | Hepatology | How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool. | 2017 | Details |
| A16290 | 28470676 | Hepatology | Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study. | 2017 | Details |
| A16291 | 28470401 | Abdom Radiol (NY) | Low-dose attenuation correction in diagnosis of non-alcoholic fatty liver disease. | 2017 | Details |
| A16292 | 28469809 | World J Hepatol | Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management. | 2017 | Details |
| A16293 | 28469795 | Am J Transl Res | MicroRNA-199a-3p attenuates hepatic lipogenesis by targeting Sp1. | 2017 | Details |
| A16294 | 28469367 | Ann Gastroenterol | Long-term change in incidence and risk factors of cirrhosis and hepatocellular carcinoma in Crete, Greece: a 25-year study. | 2017 | Details |
| A16295 | 28469366 | Ann Gastroenterol | Liver test abnormalities in patients with HIV mono-infection: assessment with simple noninvasive fibrosis markers. | 2017 | Details |
| A16298 | 28469217 | Am J Gastroenterol | Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock? | 2017 | Details |
| A16299 | 28469090 | JCI Insight | Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. | 2017 | Details |
| A16300 | 28468951 | Clin Sci (Lond) | Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease. | 2017 | Details |
| A16301 | 28468933 | J Endocrinol | The metabolic syndrome in mice overexpressing neuropeptide Y in noradrenergic neurons. | 2017 | Details |
| A16303 | 28468017 | Dig Dis | Lessons from Epidemiology: The Burden of Liver Disease. | 2017 | Details |
| A16304 | 28468015 | Dig Dis | The Role of a Dedicated Non-Alcoholic Fatty Liver Disease Clinic in 2016. | 2017 | Details |
| A16305 | 28468010 | Dig Dis | Nutrition and Liver Health. | 2017 | Details |
| A16306 | 28467925 | Cell Metab | Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16307 | 28467377 | Children (Basel) | Natural History of NAFLD Diagnosed in Childhood: A Single-Center Study. | 2017 | Details |
| A16308 | 28467181 | Exp Biol Med (Maywood) | Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems. | 2017 | Details |
| A16309 | 28465696 | J Res Med Sci | Pimpinella anisum L. fruit: Chemical composition and effect on rat model of nonalcoholic fatty liver disease. | 2017 | Details |
| A16310 | 28465298 | J Am Heart Assoc | Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study. | 2017 | Details |
| A16312 | 28464369 | Aliment Pharmacol Ther | Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. | 2017 | Details |
| A16313 | 28464337 | J Gastroenterol Hepatol | Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes. | 2018 | Details |
| A16314 | 28464257 | Aliment Pharmacol Ther | Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A16315 | 28463404 | Mol Nutr Food Res | A synbiotic composed of Lactobacillus fermentum CECT5716 and FOS prevents the development of fatty acid liver and glycemic alterations in rats fed a high fructose diet associated with changes in the microbiota. | 2017 | Details |
| A16316 | 28462811 | Trends Endocrinol Metab | Sphingolipids and Lipoproteins in Health and Metabolic Disorders. | 2017 | Details |
| A16317 | 28462384 | Cell Mol Gastroenterol Hepatol | TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice. | 2017 | Details |
| A16318 | 28462076 | Mol Metab | Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis. | 2017 | Details |
| A16319 | 28461774 | Korean J Physiol Pharmacol | Endogenous catalase delays high-fat diet-induced liver injury in mice. | 2017 | Details |
| A16320 | 28461687 | Int J Obes (Lond) | Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease. | 2017 | Details |
| A16321 | 28460349 | Cancer Epidemiol | Nonalcoholic fatty liver disease and mortality among cancer survivors. | 2017 | Details |
| A16322 | 28460180 | Can J Physiol Pharmacol | Role of folate in nonalcoholic fatty liver disease. | 2017 | Details |
| A16324 | 28458689 | Int J Endocrinol | Nonalcoholic Fatty Liver Disease and Associated Metabolic Risks of Hypertension in Type 2 Diabetes: A Cross-Sectional Community-Based Study. | 2017 | Details |
| A16325 | 28458350 | Biol Pharm Bull | Therapeutic Effect of Gypenosides on Nonalcoholic Steatohepatitis via Regulating Hepatic Lipogenesis and Fatty Acid Oxidation. | 2017 | Details |
| A16326 | 28458161 | Biomed Pharmacother | Total sesquiterpene glycosides from Loquat (Eriobotrya japonica) leaf alleviate high-fat diet induced non-alcoholic fatty liver disease through cytochrome P450 2E1 inhibition. | 2017 | Details |
| A16327 | 28458156 | Biomed Pharmacother | Protective effect of Hua Tan Qu Shi decoction against liver injury in rats with nonalcoholic fatty liver disease. | 2017 | Details |
| A16329 | 28457061 | Isr Med Assoc J | Association between Fatty Liver Disease and Hyperplastic Colonic Polyp. | 2017 | Details |
| A16330 | 28456640 | Arch Biochem Biophys | Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease. | 2017 | Details |
| A16331 | 28455679 | Curr Obes Rep | Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over. | 2017 | Details |
| A16332 | 28454924 | Toxicol Appl Pharmacol | Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecan. | 2017 | Details |
| A16333 | 28454323 | Oncol Lett | MicroRNA-29a/b/c targets iNOS and is involved in protective remote ischemic preconditioning in an ischemia-reperfusion rat model of non-alcoholic fatty liver disease. | 2017 | Details |
| A16334 | 28452727 | Georgian Med News | [THE INFLUENCE OF LIFESTYLE ON BIOMARKERS OF FIBROSIS IN PATIENTS WITH STABLE CORONARY HEART DISEASE ON THE BACKGROUND OF NON-ALCOHOLIC FATTY LIVER DISEASE]. | 2017 | Details |
| A16335 | 28452429 | Obesity (Silver Spring) | Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model. | 2017 | Details |
| A16336 | 28452101 | Diabetes Obes Metab | Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. | 2017 | Details |
| A16337 | 28449683 | Lipids Health Dis | Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway. | 2017 | Details |
| A16338 | 28449094 | Hum Mol Genet | Hepatic Tm6sf2 overexpression affects cellular ApoB-trafficking, plasma lipid levels, hepatic steatosis and atherosclerosis. | 2017 | Details |
| A16339 | 28448552 | PLoS One | Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis. | 2017 | Details |
| A16340 | 28448433 | Int J Environ Res Public Health | Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children. | 2017 | Details |
| A16341 | 28446627 | J Nutr | Silicon Alleviates Nonalcoholic Steatohepatitis by Reducing Apoptosis in Aged Wistar Rats Fed a High-Saturated Fat, High-Cholesterol Diet. | 2017 | Details |
| A16342 | 28446519 | Diabetes | Cationic Polystyrene Resolves Nonalcoholic Steatohepatitis, Obesity, and Metabolic Disorders by Promoting Eubiosis of Gut Microbiota and Decreasing Endotoxemia. | 2017 | Details |
| A16343 | 28446162 | BMC Pediatr | Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. | 2017 | Details |
| A16344 | 28446050 | Scand J Gastroenterol | Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study. | 2017 | Details |
| A16345 | 28445310 | Medicine (Baltimore) | Diagnostic accuracy of serum alanine aminotransferase as biomarker for nonalcoholic fatty liver disease and insulin resistance in healthy subjects, using 3T MR spectroscopy. | 2017 | Details |
| A16346 | 28445256 | Medicine (Baltimore) | Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patients. | 2017 | Details |
| A16347 | 28445156 | Oncotarget | Dietary capsaicin and antibiotics act synergistically to reduce non-alcoholic fatty liver disease induced by high fat diet in mice. | 2017 | Details |
| A16348 | 28443804 | J Am Coll Nutr | 25(OH)D Levels in Relation to Gender, Overweight, Insulin Resistance, and Inflammation in a Cross-Sectional Cohort of Northern Italian Workers: Evidence in Support of Preventive Health Care Programs. | 2017 | Details |
| A16349 | 28443702 | J Am Coll Nutr | Turmeric Supplementation Improves Serum Glucose Indices and Leptin Levels in Patients with Nonalcoholic Fatty Liver Diseases. | 2017 | Details |
| A16350 | 28443155 | World J Hepatol | Egg consumption and risk of non-alcoholic fatty liver disease. | 2017 | Details |
| A16351 | 28442522 | Ann Clin Lab Sci | Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease. | 2017 | Details |
| A16352 | 28442507 | J Endocrinol | Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice. | 2017 | Details |
| A16353 | 28442273 | Mol Aspects Med | The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2017 | Details |
| A16354 | 28442120 | Gastroenterology | American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. | 2017 | Details |
| A16355 | 28441694 | J Hypertens | Arterial stiffness is increased in nondiabetic, nonhypertensive postmenopausal women with nonalcoholic fatty liver disease. | 2017 | Details |
| A16356 | 28441459 | PLoS One | Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study. | 2017 | Details |
| A16357 | 28441156 | Curr Opin Lipidol | Interpreting lipoproteins in nonalcoholic fatty liver disease. | 2017 | Details |
| A16358 | 28439482 | Cureus | Association of Non-alcoholic Fatty Liver Disease with Conduction Defects on Electrocardiogram. | 2017 | Details |
| A16359 | 28439416 | Biomark Res | Burden of hepatocellular carcinoma among hispanics in South Texas: a systematic review. | 2017 | Details |
| A16360 | 28437890 | Biomed Pharmacother | Does propolis have any effect on non-alcoholic fatty liver disease? | 2017 | Details |
| A16361 | 28437865 | Hepatology | A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH). | 2017 | Details |
| A16362 | 28437863 | Hepatology | Sirtuin 3 acts as a negative regulator of autophagy dictating hepatocyte susceptibility to lipotoxicity. | 2017 | Details |
| A16363 | 28436986 | Nat Genet | Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci. | 2017 | Details |
| A16364 | 28436456 | Sci Rep | Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida. | 2017 | Details |
| A16365 | 28436449 | Sci Rep | Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. | 2017 | Details |
| A16366 | 28436198 | Mol Nutr Food Res | Effects of selenium on apoptosis and abnormal amino acid metabolism induced by excess fatty acid in isolated rat hepatocytes. | 2017 | Details |
| A16369 | 28434046 | Amino Acids | Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis. | 2017 | Details |
| A16370 | 28432400 | Internist (Berl) | [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis]. | 2017 | Details |
| A16371 | 28431668 | Diabetes Metab | GLP-1 receptor agonists in NAFLD. | 2017 | Details |
| A16372 | 28430371 | APMIS | Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease. | 2017 | Details |
| A16373 | 28429814 | Food Funct | Sulfated polysaccharides from Enteromorpha prolifera suppress SREBP-2 and HMG-CoA reductase expression and attenuate non-alcoholic fatty liver disease induced by a high-fat diet. | 2017 | Details |
| A16374 | 28429344 | Eur Rev Med Pharmacol Sci | Up-regulation of microRNA-367 promotes liver steatosis through repressing TBL1 in obese mice. | 2017 | Details |
| A16375 | 28429199 | Curr Gastroenterol Rep | Gastric Bypass and Influence on Improvement of NAFLD. | 2017 | Details |
| A16376 | 28428634 | Nat Rev Gastroenterol Hepatol | Lipid droplets and liver disease: from basic biology to clinical implications. | 2017 | Details |
| A16377 | 28428362 | J Endocrinol | Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones. | 2017 | Details |
| A16378 | 28428116 | Pharmacol Res | Cycloastragenol improves hepatic steatosis by activating farnesoid X receptor signalling. | 2017 | Details |
| A16379 | 28427239 | Oncotarget | Foxo3a-dependent Bim transcription protects mice from a high fat diet via inhibition of activation of the NLRP3 inflammasome by facilitating autophagy flux in Kupffer cells. | 2017 | Details |
| A16380 | 28426902 | Liver Transpl | Hepatic steatosis after pediatric liver transplant. | 2017 | Details |
| A16381 | 28426878 | Carcinogenesis | Microbiota, NASH, HCC and the potential role of probiotics. | 2017 | Details |
| A16382 | 28426876 | Carcinogenesis | Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis. | 2017 | Details |
| A16383 | 28426815 | PLoS One | Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study. | 2017 | Details |
| A16384 | 28425467 | Sci Rep | Hyperpolarized 13C Spectroscopic Evaluation of Oxidative Stress in a Rodent Model of Steatohepatitis. | 2017 | Details |
| A16385 | 28425408 | Ann Hepatol | Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis. | 2017 | Details |
| A16386 | 28425401 | Ann Hepatol | MRE in NAFLD: Promising but Further Validation is Required. | 2017 | Details |
| A16387 | 28425154 | Hepatol Res | Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study. | 2017 | Details |
| A16388 | 28424263 | J Biol Chem | The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice. | 2017 | Details |
| A16389 | 28422962 | PLoS One | Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. | 2017 | Details |